Literature DB >> 21262869

Correlates of acute insulin resistance in the early phase of non-diabetic ST-elevation myocardial infarction.

Chiara Lazzeri1, Serafina Valente, Marco Chiostri, Claudio Picariello, Gian Franco Gensini.   

Abstract

The relationship between insulin secretion and acute insulin resistance (as assessed by Homeostatic Model Assessment [HOMA] index) and clinical and biochemical parameters in the early phase of non-diabetic ST-elevation myocardial infarction (STEMI) is so far unexplored. We aimed at assessing this relation in 286 consecutive STEMI patients without previously known diabetes submitted to primary percutaneous coronary intervention (PCI). Insulin resistance (as indicated by HOMA) was detectable in 67.1%. Non-parametric correlation showed that HOMA index was significantly correlated with BMI (r = 0.242; p < 0.0001) and HbA(1c) (r = 0.189; p < 0.001). At multivariable backward linear regression analysis, glycaemia was directly related to leukocyte count (p = 0.0003), age (p = 0.0001), creatine kinase isoform MB (CK-MB) (p = 0.00278) and lactate (p < 0.0001). Insulin was directly and significantly related to glycaemia (p = 0.0006), body mass index (BMI) (p = 0.00028) and lactate (p = 0.0096) In the early phase of STEMI without previously known diabetes the acute glucose dysmetabolism is quite complex, comprising increased glucose values and the development of acute insulin resistance. While insulin secretion is strictly related to BMI, apart from glucose levels, increased glucose values can be mainly related to the acute inflammatory response (as indicated to leukocyte count and C-RP), to age and to the degree of myocardial damage (as inferred by CK-MB).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21262869     DOI: 10.1177/1479164110396744

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  7 in total

1.  Impact of hypertension on short- and long-term prognoses in patients with ST elevation myocardial infarction and without previously known diabetes.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Paola Attanà; Claudio Picariello; Gian Franco Gensini
Journal:  Heart Vessels       Date:  2011-07-07       Impact factor: 2.037

Review 2.  Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Maria Grazia D'Alfonso; Gian Franco Gensini
Journal:  World J Cardiol       Date:  2014-04-26

3.  Hyperglycemia, acute insulin resistance, and renal dysfunction in the early phase of ST-elevation myocardial infarction without previously known diabetes: impact on long-term prognosis.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Paola Attanà; Alessio Mattesini; Martina Nesti; Gian Franco Gensini
Journal:  Heart Vessels       Date:  2013-10-20       Impact factor: 2.037

4.  Lipoprotein ratios as surrogate markers for insulin resistance in South indians with normoglycemic nondiabetic acute coronary syndrome.

Authors:  Medha Rajappa; M G Sridhar; J Balachander; K R Sethuraman; Kalai Selvi Rajendiran
Journal:  ISRN Endocrinol       Date:  2014-05-18

5.  Hyperlactatemia and the Outcome of Type 2 Diabetic Patients Suffering Acute Myocardial Infarction.

Authors:  Jovanovic Aleksandar; Peric Vladan; Snezana Markovic-Jovanovic; Radojica Stolic; Jadranka Mitic; Tanja Smilic
Journal:  J Diabetes Res       Date:  2016-11-16       Impact factor: 4.011

6.  Impact of Acute Insulin Resistance on Myocardial Blush in Non-Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Soheir M Kasem; Ghada Mohamed Saied; Abdel Nasser Ma Hegazy; Mahmoud Abdelsabour
Journal:  Front Cardiovasc Med       Date:  2021-05-10

7.  Acute insulin resistance in ST-segment elevation myocardial infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function.

Authors:  Danijela Trifunovic; Sanja Stankovic; Dragana Sobic-Saranovic; Jelena Marinkovic; Marija Petrovic; Dejan Orlic; Branko Beleslin; Marko Banovic; Bosiljka Vujisic-Tesic; Milan Petrovic; Ivana Nedeljkovic; Jelena Stepanovic; Ana Djordjevic-Dikic; Milorad Tesic; Nina Djukanovic; Olga Petrovic; Olga Vasovic; Emilija Nestorovic; Jelena Kostic; Arsen Ristic; Miodrag Ostojic
Journal:  Cardiovasc Diabetol       Date:  2014-04-05       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.